These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 26771352)

  • 1. Overcoming Pluripotent Stem Cell Dependence on the Repair of Endogenous DNA Damage.
    Chlon TM; Ruiz-Torres S; Maag L; Mayhew CN; Wikenheiser-Brokamp KA; Davies SM; Mehta P; Myers KC; Wells JM; Wells SI
    Stem Cell Reports; 2016 Jan; 6(1):44-54. PubMed ID: 26771352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An ATR- and BRCA1-mediated Fanconi anemia pathway is required for activating the G2/M checkpoint and DNA damage repair upon rereplication.
    Zhu W; Dutta A
    Mol Cell Biol; 2006 Jun; 26(12):4601-11. PubMed ID: 16738325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation of an induced pluripotent stem cell line that mimics the disease phenotypes from a patient with Fanconi anemia by conditional complementation.
    Bharathan SP; Nandy K; Palani D; Janet A NB; Natarajan K; George B; Srivastava A; Velayudhan SR
    Stem Cell Res; 2017 Apr; 20():54-57. PubMed ID: 28395741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FANCD2 monoubiquitination and activation by hexavalent chromium [Cr(VI)] exposure: activation is not required for repair of Cr(VI)-induced DSBs.
    Vilcheck SK; Ceryak S; O'Brien TJ; Patierno SR
    Mutat Res; 2006 Nov; 610(1-2):21-30. PubMed ID: 16893675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation of iPSCs from genetically corrected Brca2 hypomorphic cells: implications in cell reprogramming and stem cell therapy.
    Navarro S; Moleiro V; Molina-Estevez FJ; Lozano ML; Chinchon R; Almarza E; Quintana-Bustamante O; Mostoslavsky G; Maetzig T; Galla M; Heinz N; Schiedlmeier B; Torres Y; Modlich U; Samper E; Río P; Segovia JC; Raya A; Güenechea G; Izpisua-Belmonte JC; Bueren JA
    Stem Cells; 2014 Feb; 32(2):436-46. PubMed ID: 24420904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA repair: exploiting the Fanconi anemia pathway as a potential therapeutic target.
    Hucl T; Gallmeier E
    Physiol Res; 2011; 60(3):453-65. PubMed ID: 21401292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent discoveries in the molecular pathogenesis of the inherited bone marrow failure syndrome Fanconi anemia.
    Mamrak NE; Shimamura A; Howlett NG
    Blood Rev; 2017 May; 31(3):93-99. PubMed ID: 27760710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High levels of RAD51 perturb DNA replication elongation and cause unscheduled origin firing due to impaired CHK1 activation.
    Parplys AC; Seelbach JI; Becker S; Behr M; Wrona A; Jend C; Mansour WY; Joosse SA; Stuerzbecher HW; Pospiech H; Petersen C; Dikomey E; Borgmann K
    Cell Cycle; 2015; 14(19):3190-202. PubMed ID: 26317153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overcoming reprogramming resistance of Fanconi anemia cells.
    Müller LU; Milsom MD; Harris CE; Vyas R; Brumme KM; Parmar K; Moreau LA; Schambach A; Park IH; London WB; Strait K; Schlaeger T; Devine AL; Grassman E; D'Andrea A; Daley GQ; Williams DA
    Blood; 2012 Jun; 119(23):5449-57. PubMed ID: 22371882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Analysis of irradiation-induced repair foci in mouse embryonic stem cells].
    Suvorova II; Pospelov VA
    Tsitologiia; 2014; 56(5):340-5. PubMed ID: 25696973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brief report: human pluripotent stem cell models of fanconi anemia deficiency reveal an important role for fanconi anemia proteins in cellular reprogramming and survival of hematopoietic progenitors.
    Yung SK; Tilgner K; Ledran MH; Habibollah S; Neganova I; Singhapol C; Saretzki G; Stojkovic M; Armstrong L; Przyborski S; Lako M
    Stem Cells; 2013 May; 31(5):1022-9. PubMed ID: 23280624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BRCA1 Is Required for Maintenance of Phospho-Chk1 and G2/M Arrest during DNA Cross-Link Repair in DT40 Cells.
    Draga M; Madgett EB; Vandenberg CJ; du Plessis D; Kaufmann A; Werler P; Chakraborty P; Lowndes NF; Hiom K
    Mol Cell Biol; 2015 Nov; 35(22):3829-40. PubMed ID: 26324327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A defined role for multiple Fanconi anemia gene products in DNA-damage-associated ubiquitination.
    Tan W; Deans AJ
    Exp Hematol; 2017 Jun; 50():27-32. PubMed ID: 28315701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of CHK1 function impedes DNA damage-induced FANCD2 monoubiquitination but normalizes the abnormal G2 arrest in Fanconi anemia.
    Guervilly JH; Macé-Aimé G; Rosselli F
    Hum Mol Genet; 2008 Mar; 17(5):679-89. PubMed ID: 18029388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. hMSH5 Facilitates the Repair of Camptothecin-induced Double-strand Breaks through an Interaction with FANCJ.
    Xu Y; Wu X; Her C
    J Biol Chem; 2015 Jul; 290(30):18545-58. PubMed ID: 26055704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inducibility of nuclear Rad51 foci after DNA damage distinguishes all Fanconi anemia complementation groups from D1/BRCA2.
    Godthelp BC; Wiegant WW; Waisfisz Q; Medhurst AL; Arwert F; Joenje H; Zdzienicka MZ
    Mutat Res; 2006 Feb; 594(1-2):39-48. PubMed ID: 16154163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Attenuation of the formation of DNA-repair foci containing RAD51 in Fanconi anaemia.
    Digweed M; Rothe S; Demuth I; Scholz R; Schindler D; Stumm M; Grompe M; Jordan A; Sperling K
    Carcinogenesis; 2002 Jul; 23(7):1121-6. PubMed ID: 12117768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The role of the Fanconi anemia pathway in DNA repair and maintenance of genome stability].
    Koczorowska AM; Białkowska A; Kluzek K; Zdzienicka MZ
    Postepy Hig Med Dosw (Online); 2014 May; 68():459-72. PubMed ID: 24864098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct interaction of the Fanconi anaemia protein FANCG with BRCA2/FANCD1.
    Hussain S; Witt E; Huber PA; Medhurst AL; Ashworth A; Mathew CG
    Hum Mol Genet; 2003 Oct; 12(19):2503-10. PubMed ID: 12915460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CHK1 inhibition as a strategy for targeting Fanconi Anemia (FA) DNA repair pathway deficient tumors.
    Chen CC; Kennedy RD; Sidi S; Look AT; D'Andrea A
    Mol Cancer; 2009 Apr; 8():24. PubMed ID: 19371427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.